Pubblicazioni Scientifiche

Le pubblicazioni scientifiche

I risultati di tutti gli studi condotti dalla FIL vengono presentati ai maggiori congressi nazionali e internazionali e inviati per la pubblicazione a riviste recensite.  

Di seguito l’elenco delle pubblicazioni direttamente derivanti da attività di ricerca FIL o lavori per cui la FIL ha fornito supporto scientifico ad altri promotori e partner di ricerca.

Cliccando sul titolo sarà possibile accedere direttamente a PubMed o ad altri portali in cui è possibile trovare gli abstract o, ove disponibili, i testi completi delle pubblicazioni.

 

Data Rivista Titolo Autori
2022 Hematological oncology OBINUTUZUMAB DOES NOT IMPROVE COMPLETE METABOLIC RESPONSE BUT DOES NOT COMPROMISE MOBILIZATION OR ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN DIFFUSE LARGE B CELL LYMPHOMA: RESULTS FROM A FIL PROSPECTIVE PHASE II STUDY (THE GIOTTO STUDY) Luigi Rigacci, Roberta Battistini, Sofia Kovalchuk, Valerio Zoli, Benedetta Puccini, Andrea Evangelista, Luca Arcaini, Leonardo Flenghi, Carlo Visco, Michael Mian, Alice Di Rocco, Claudia Peracchio, Manuel Gotti, Maria Chiara Tisi, Francesca Palombi, Samantha Pozzi, Daniela Gioia, Piera Viero, Maurizio Martelli
2022 Leukemia Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, Christopher P Fox, Elisabeth Schorb, Claudia Celico, Monica Falautano, Alessandro Nonis, Paul La Rosée, Mascia Binder, Alberto Fabbri, Fiorella Ilariucci, Mauro Krampera, Alexander Roth, Claire Hemmaway, Peter W Johnson, Kim M Linton, Tobias Pukrop, Jettes Sønderskov Gørløv, Monica Balzarotti, Georg Hess, Ulrich Keller, Stephan Stilgenbauer, Jense Panse, Alessandra Tucci, Lorella Orsucci, Francesco Pisani, Manuela Zanni, Stefan W Krause, Hans J Schmoll, Bernd Hertenstein, Mathias Rummel, Jeffery Smith, Lorenz Thurner, Giuseppina Cabras, Elsa Pennese, Maurilio Ponzoni, Martina Deckert, Letterio S Politi, Jurgen Finke, Antonella Ferranti, Kelly Cozens, Elvira Burger, Nicoletta Ielmini, Franco Cavalli, Emanuele Zucca, Gerald Illerhaus, IELSG32 study investigators
2022 Haematologica Autologous stem cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study Alejandro Martín García-Sancho, Monica Bellei, Miriam López-Parra, Giuseppe Gritti, María Cortés, Silvana Novelli, Carlos Panizo, Luigi Petrucci, Antonio Gutiérrez, Ivan Dlouhy, Mariana Bastos-Oreiro, Juan M Sancho, María J Ramírez, José M Moraleda, Estrella Carrillo, Ana I Jiménez-Ubieto, Isidro Jarque, Lorella Orsucci, Estefanía García-Torres, Carlos Montalbán, Anna Dodero, Reyes Arranz, Natalia De Las Heras, María J Pascual, Javier López-Jiménez, Michelle Spina, Alessandro Re, Sonia González De Villambrosia, Sabela Bobillo, Massimo Federico, Dolores Caballero
2022 Cancers Late Endocrine and Metabolic Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi Sergio Di Molfetta, Antonella Daniele, Chiara Gerardi, Eleonora Allocati, Carla Minoia, Giacomo Loseto, Francesco Giorgino, Attilio Guarini, Vitaliana De Sanctis
2022 Cancers Second Cancers in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review by the Fondazione Italiana Linfomi Luca Nassi, Vitaliana De Sanctis, Giacomo Loseto, Chiara Gerardi, Eleonora Allocati, Sabino Ciavarella, Carla Minoia, Attilio Guarini, Alessia Bari
2022 Hematological oncology Brentuximab vedotin in The Treatment of Relapsed/Refractory CD30+ Peripheral T-cell Lymphoma: a FIL Phase 2 Study Vittorio Stefoni, Cinzia Pellegrini, Lisa Argnani, Paolo Corradini, Anna Dodero, Lorella Orsucci, Stefano Volpetti, Pier Luigi Zinzani
2022 Cancers Late Cardiological Sequelae and Long-Term Monitoring in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana LinfomiBrentuximab vedotin in The Treatment of Relapsed/Refractory CD30+ Peripheral T-cell Lymphoma: a FIL Phase 2 Study Stefano Oliva, Agata Puzzovivo, Chiara Gerardi, Eleonora Allocati, Vitaliana De Sanctis, Carla Minoia, Tetiana Skrypets, Attilio Guarini, Guido Gini
2022 Cancers A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III TrialLate Cardiological Sequelae and Long-Term Monitoring in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana LinfomiBrentuximab vedotin in The Treatment of Relapsed/Refractory CD30+ Peripheral T-cell Lymphoma: a FIL Phase 2 Study Gian Maria Zaccaria, Simone Ferrero, Eva Hoster, Roberto Passera, Andrea Evangelista, Elisa Genuardi, Daniela Drandi, Marco Ghislieri, Daniela Barbero, Ilaria Del Giudice, Monica Tani, Riccardo Moia, Stefano Volpetti, Maria Giuseppina Cabras, Nicola Di Renzo, Francesco Merli, Daniele Vallisa, Michele Spina, Anna Pascarella, Giancarlo Latte, Caterina Patti, Alberto Fabbri, Attilio Guarini, Umberto Vitolo, Olivier Hermine, Hanneke C Kluin-Nelemans, Sergio Cortelazzo, Martin Dreyling, Marco Ladetto
2021 Lancet Hematology MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial Andrés J M Ferreri, Jeanette K Doorduijn, Alessandro Re, Maria Giuseppina Cabras, Jeffery Smith, Fiorella Ilariucci, Mario Luppi, Teresa Calimeri, Chiara Cattaneo, Jahanzaib Khwaja, Barbara Botto, Claudia Cellini, Luca Nassi, Kim Linton, Pam McKay, Jacopo Olivieri, Caterina Patti, Francesca Re, Alessandro Fanni, Vikram Singh, Jacoline E C Bromberg, Kelly Cozens, Elisabetta Gastaldi, Massimo Bernardi, Nicola Cascavilla, Andrew Davies, Christopher P Fox, Maurizio Frezzato, Wendy Osborne, Anna Marina Liberati, Urban Novak, Renato Zambello, Emanuele Zucca, Kate Cwynarski, International Extranodal Lymphoma Study Group (IELSG)
2021 Frontiers in Oncology Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi Laura Ballotta, Pier Luigi Zinzani, Stefano Pileri, Riccardo Bruna, Monica Tani, Beatrice Casadei, Valentina Tabanelli, Stefano Volpetti, Stefano Luminari, Paolo Corradini, Elisa Lucchini, Maria Chiara Tisi, Michele Merli, Alessandro Re, Marzia Varettoni, Emanuela Anna Pesce, Francesco Zaja
2021 British journal of haematology Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial Chiappella A, Diop F, Agostinelli C, Novo M, Nassi L, Evangelista A, Ciccone G, Di Rocco A, Martelli M, Melle F, Moia R, Motta G, Righi S, Santambrogio E, Tucci A, Balzarotti M, Ladetto M, Pileri SA, Gaidano G, Vitolo U; Fondazione Italiana Linfomi (FIL).
2021 Frontiers in Oncology CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL) Guido Gini, Alice Di Rocco, Luca Nassi, Annalisa Arcari, Maria Chiara Tisi, Giacomo Loseto, Michela Sampaolo, Massimo Gentile, Ombretta Annibali, Andrés José María Ferreri, Monica Balzarotti
2021 European Journal of Cancer Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma Sara Alonso-Álvarez, Martina Manni, Silvia Montoto, Clémentine Sarkozy, Franck Morschhauser, Marielle J Wondergem, Attilio Guarini, Laura Magnano, Miguel Alcoceba, Martine Chamuleau, Sara Galimberti, Maria Gomes da Silva, Harald Holte, Emanuele Zucca, Sandra Lockmer, Igor Aurer, Luigi Marcheselli, Yana Stepanishyna, María Dolores Caballero Barrigón, Gilles Salles, Massimo Federico
2021 Journal of clinical oncology Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study Stefano Luminari, Martina Manni, Sara Galimberti, Annibale Versari, Alessandra Tucci, Carola Boccomini, Lucia Farina, Jacopo Olivieri, Luigi Marcheselli, Luca Guerra, Simone Ferrero, Luca Arcaini, Federica Cavallo, Sofya Kovalchuk, Tetiana Skrypets, Ilaria Del Giudice, Stephane Chauvie, Caterina Patti, Caterina Stelitano, Francesca Ricci, Antonello Pinto, Gloria Margiotta Casaluci, Vittorio R Zilioli, Anna Merli, Marco Ladetto, Silvia Bolis, Vincenzo Pavone, Annalisa Chiarenza, Annalisa Arcari, Antonella Anastasia, Alessandra Dondi, Donato Mannina, Massimo Federico, Fondazione Italiana Linfomi
2021 Hematological oncology Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience Fulvio Massaro, Vincenzo Pavone, Piero Maria Stefani, Barbara Botto, Alessandro Pulsoni, Caterina Patti, Maria Cantonetti, Andrea Visentin, Potito Rosario Scalzulli, Andrea Rossi, Sara Galimberti, Michele Cimminiello, Guido Gini, Maurizio Musso, Marco Sorio, Annalisa Arcari, Vittorio Ruggero Zilioli, Mario Luppi, Donato Mannina, Alberto Fabbri, Giuseppe Pietrantuono, Ombretta Annibali, Agostino Tafuri, Eleonora Prete, Antonino Mulè, Elisa Barbolini, Luigi Marcheselli, Stefano Luminari, Francesco Merli
2021 Blood Advances A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study Carlo Visco, Luigi Marcheselli, Roberto Mina, Marianna Sassone, Anna Guidetti, Domenico Penna, Chiara Cattaneo, Valentina Bonuomo, Alessandro Busca, Andrés J M Ferreri, Riccardo Bruna, Luigi Petrucci, Roberto Cairoli, Marco Salvini, Lorenza Bertù, Marco Ladetto, Sofia Pilerci, Antonello Pinto, Safaa Ramadan, Francesco Marchesi, Michele Cavo, Luca Arcaini, Elisa Coviello, Alessandra Romano, Pellegrino Musto, Massimo Massaia, Nicola Stefano Fracchiolla, Monia Marchetti, Annamaria Scattolin, Maria Chiara Tisi, Antonio Cuneo, Matteo G Della Porta, Livio Trentin, Mauro Turrini, Filippo Gherlinzoni, Agostino Tafuri, Sara Galimberti, Monica Bocchia, Valeria Cardinali, Daniela Cilloni, Alessandro Corso, Daniele Armiento, Luigi Rigacci, Elettra Ortu La Barbera, Carlo B Gambacorti-Passerini, Giuseppe Visani, Daniele Vallisa, Adriano Venditti, Carmine Selleri, Annarita Conconi, Patrizia Tosi, Francesco Lanza, Anna Candoni, Mauro Krampera, Paolo Corradini, Francesco Passamonti, Francesco Merli
2021 Leukemia & Lymphoma Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana Linfomi Annalisa Arcari, Lucia Morello, Daniele Vallisa, Luigi Marcheselli, Cristina Tecchio, Francesca Maria Quaglia, Maria Chiara Tisi, Vittorio Ruggero Zilioli, Alice Di Rocco, Tommasina Perrone, Guido Gini, Irene Dogliotti, Nicola Bianchetti, Valentina Bozzoli, Chiara De Philippis, Maria Isabel Alvarez De Celis, Annalisa Chiappella, Alberto Fabbri, Matteo Pelosini, Michele Merli, Anna Lia Molinari, Roberta Sciarra, Stefano Volpetti, Stefan Hohaus, Luca Nassi, Carlo Visco
2021 Blood Advances Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial​ Umberto Ricardi, Mario Levis, Andrea Evangelista, Daniela Maria Gioia, Gian Mauro Sacchetti, Manuel Gotti, Alessandro Re, Michela Buglione, Vincenzo Pavone, Antonio Nardella, Luca Nassi, Manuela Zanni, Paola Franzone, Giovanni Piero Frezza, Alessandro Pulsoni, Lavinia Grapulin, Armando Santoro, Luigi Rigacci, Gabriele Simontacchi, Monica Tani, Francesco Zaja, Elisabetta Abruzzese, Barbara Botto, Vittorio Ruggero Zilioli, Delia Rota-Scalabrini, Roberto Freilone, Giovannino Ciccone, Andrea Riccardo Filippi, Pier Luigi Zinzani
2021 Hemasphere Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network Barbara Mantoan, Elisa Genuardi, Martina Ferrante, Irene Della Starza, Elena Ciabatti, Susanna Grassi, Lucia Anna De Novi, Marzia Cavalli, Claudia Mannu, Anna Gazzola, Riccardo Bomben, Massimo Degan, Beatrice Alessandria, Christiane Pott, Marie-Hélène Delfau-Larue, Ramon García-Sanz, Claudio Agostinelli, Valter Gattei, Sara Galimberti, Ilaria Del Giudice, Gianluca Gaidano, Marco Ladetto, Simone Ferrero, Daniela Drandi
2021 Tumori Journal Fertility preservation strategies for patients with lymphoma: a real-world practice survey among Fondazione Italiana Linfomi centers Simonetta Viviani , Miriam Dellino, Safaa Ramadan, Claudia Peracchio, Luigi Marcheselli, Carla Minoia
and Attilio Guarini, on behalf of the FIL Lymphoma Survivorship Committee
2021 Hematological oncology Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma Elisa Genuardi, Petra Klous, Barbara Mantoan, Daniela Drandi, Martina Ferrante, Federica Cavallo, Beatrice Alessandria, Irene Dogliotti, Daniele Grimaldi, Simone Ragaini, Michele Clerico, Mariella Lo Schirico, Elona Saraci, Mehmet Yilmaz, Gian Maria Zaccaria, Sergio Cortelazzo, Umberto Vitolo, Stefano Luminari, Massimo Federico, Mario Boccadoro, Max van Min, Erik Splinter, Marco Ladetto, Simone Ferrero
2021 Annals of Hematology Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi Armando Santoro, Rita Mazza, Michele Spina, Catello Califano, Giorgina Specchia, Michele Carella, Ugo Consoli, Francesca Palombi, Maurizio Musso, Alessandro Pulsoni, Sofya Kovalchuk, Maurizio Bonfichi, Francesca Ricci, Alberto Fabbri, Anna Marina Liberati, Marcello Rodari, Laura Giordano, Emanuela Chimienti, Monica Balzarotti, Roberto Sorasio, Andrea Gallamini, Chiara Ghiggi, Patrizia Ciammella, Umberto Ricardi, Stephane Chauvie, Carmelo Carlo-Stella, Francesco Merli
2021 British journal of haematology COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies Passamonti F, Romano A, Salvini M, Merli F, Porta MGD, Bruna R, Coviello E, Romano I, Cairoli R, Lemoli R, Farina F, Venditti A, Busca A, Ladetto M, Massaia M, Pinto A, Arcaini L, Tafuri A, Marchesi F, Fracchiolla N, Bocchia M, Armiento D, Candoni A, Krampera M, Luppi M, Cardinali V, Galimberti S, Cattaneo C, La Barbera EO, Mina R, Lanza F, Visani G, Musto P, Petrucci L, Zaja F, Grossi PA, Bertù L, Pagano L, Corradini P; ITA-HEMA-COV Investigators*
2021 Cancers The Impact of Healthy Lifestyles on Late Sequelae in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors. A Systematic Review by the Fondazione Italiana Linfomi Carla Minoia, Chiara Gerardi, Eleonora Allocati, Antonella Daniele, Vitaliana De Sanctis, Alessia Bari, Attilio Guarini
2021 Cancers Long-Term Follow-Up of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: Aims and Methodological Approach for Fondazione Italiana Linfomi Systematic Reviews Chiara Gerardi, Eleonora Allocati, Carla Minoia, Attilio Guarini, Rita Banzi
2021 Cancers Male and Female Fertility: Prevention and Monitoring Hodgkin’ Lymphoma and Diffuse Large B-Cell Lymphoma Adult Survivors, A Systematic Review by the Fondazione Italiana Linfomi Simonetta Viviani, Valentina Caccavari, Chiara Gerardi, Safaa Ramadan, Eleonora Allocati, Carla Minoia, Attilio Guarini, Anna Di Russo
2021 Cancers Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi Silvia Franceschetti, Maria Antonietta Annunziata, Giulia Agostinelli, Chiara Gerardi, Eleonora Allocati, Carla Minoia, Attilio Guarini
2021 British journal of haematology Application of the Euro Clonality next-generation sequencing-based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial Elisa Genuardi, Greta Romano, Marco Beccuti, Beatrice Alessandria, Donato Mannina, Catello Califano, Delia Rota Scalabrini, Sergio Cortelazzo, Marco Ladetto, Simone Ferrero, Raffaele A Calogero, Francesca Cordero
2021 Journal of clinical oncology ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma Grzegorz S Nowakowski, Annalisa Chiappella, Randy D Gascoyne, David W Scott, Qingyuan Zhang, Wojciech Jurczak, Muhit Özcan, Xiaonan Hong, Jun Zhu, Jie Jin, David Belada, Juan Miguel Bergua, Francesco Piazza, Heidi Mócikova, Anna Lia Molinari, Dok Hyun Yoon, Federica Cavallo, Monica Tani, Kazuhito Yamamoto, Koji Izutsu, Koji Kato, Myron Czuczman, Sarah Hersey, Adrian Kilcoyne, Jacqueline Russo, Krista Hudak, Jingshan Zhang, Steve Wade, Thomas E Witzig, Umberto Vitolo
2021 Journal of clinical oncology Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi Merli F, Luminari S, Tucci A, Arcari A, Rigacci L, Hawkes E, Chiattone CS, Cavallo F, Cabras G, Alvarez I, Fabbri A, Re A, Puccini B, Barraclough A, Delamain MT, Ferrero S, Usai SV, Ferrari A, Cencini E, Pennese E, Zilioli VR, Marino D, Balzarotti M, Cox MC, Zanni M, Di Rocco A, Lleshi A, Botto B, Hohaus S, Merli M, Sartori R, Gini G, Nassi L, Musuraca G, Tani M, Bottelli C, Kovalchuk S, Re F, Flenghi L, Molinari A, Tarantini G, Chimienti E, Marcheselli L, Mammi C, Spina M.
2021 Blood ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project Andrei Shustov, Maria Elena Cabrera, Monica Civallero, Monica Bellei, Young Hyeh Ko, Martina Manni, Tetiana Skrypets, Steven M Horwitz, Carmino Antonio De Souza, John A Radford, Sabela Bobillo, Maria Virginia Prates, Andrés J M Ferreri, Carlos Chiattone, Michele Spina, Julie M Vose, Annalisa Chiappella, Daniele Laszlo, Dario Marino, Caterina Stelitano, Massimo Federico
2021 British Journal of Haematology A brief rituximab, bendamustine, mitoxantrone (R-BM) induc-
tion followed by rituximab consolidation in elderly patients
with advanced follicular lymphoma: a phase II study by the
Fondazione Italiana Linfomi (FIL)
Carola Boccomini, Marco Ladetto, Luigi Rigacci, Benedetta Puccini, Sara Rattotti, Stefano Volpetti, Simone Ferrero, Annalisa Chiarenza, Roberto Freilone, Mattia Novo, Paolo Corradini, Luca Nassi, Chiara Rusconi, Caterina Stelitano, Silvia Bolis, Anna Marina Liberati, Alessandra Tucci, Luca Baldini, Monica Balzarotti, Andrea Evangelista, Giovannino Ciccone, Umberto Vitolo
2021 The Lancet Haematology Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial Marco Ladetto, Sergio Cortelazzo, Simone Ferrero, Andrea Evangelista, Michael Mian, Rita Tavarozzi, Manuela Zanni, Federica Cavallo, Alice Di Rocco, Vittorio Stefoni, Chiara Pagani, Alessandro Re, Annalisa Chiappella, Monica Balzarotti, Vittorio R Zilioli, Maria Gomes da Silva, Luca Arcaini, Anna L Molinari, Filippo Ballerini, Andrés J M Ferreri, Benedetta Puccini, Fabio Benedetti, Piero M Stefani, Franco Narni, Ivana Casaroli, Caterina Stelitano, Giovannino Ciccone, Umberto Vitolo, Maurizio Martelli
2020 Annals of hematology Correction to: The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of pet-guided treatments Alessia Bari, Raffaella Marcheselli, Stefano Sacchi, Alessandro Re, Chiara Pagani, Alessandra Tucci, Barbara Botto, Umberto Vitolo, Anna Lia Molinari, Benedetta Puccini, Alessandro Pulsoni, Armando Santoro, Monica Tani, Luca Nassi, Erika Meli, Vincenzo Pavone, Maurizio Bonfichi, Andrea Evangelista, Daniela Gioia, Alessandro Levis, Pierluigi Zinzani, Fondazione Italiana Linfomi (Onlus)
2020 Hematological oncology Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity Luigi Rigacci, Ombretta Annibali, Sofya Kovalchuk, Elisabetta Bonifacio, Francesca Pregnolato, Francesco Angrilli, Umberto Vitolo, Samantha Pozzi, Serena Broggi, Stefano Luminari, Francesco Merli, Michele Spina, Silvia Bolis, Gloria Margiotta-Casaluci, Rosario Scalzulli, Christina Cox, Angela Maria Mamusa, Armando Santoro, Pier Luigi Zinzani, Samantha Ferrari, Guido Gini, Maria Luigia Vigliotti, Antonino Mulè, Leonardo Flenghi, Fondazione Italiana Linfomi (FIL)
2020 The Lancet Haematology Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study Passamonti F, Cattaneo C, Arcaini L, Bruna R, Cavo M, Merli F, Angelucci E, Krampera M, Cairoli R, Della Porta MG, Fracchiolla N, Ladetto M, Gambacorti Passerini C, Salvini M, Marchetti M, Lemoli R, Molteni A, Busca A, Cuneo A, Romano A, Giuliani N, Galimberti S, Corso A, Morotti A, Falini B, Billio A, Gherlinzoni F, Visani G, Tisi MC, Tafuri A, Tosi P, Lanza F, Massaia M, Turrini M, Ferrara F, Gurrieri C, Vallisa D, Martelli M, Derenzini E, Guarini A, Conconi A, Cuccaro A, Cudillo L, Russo D, Ciambelli F, Scattolin AM, Luppi M, Selleri C, Ortu La Barbera E, Ferrandina C, Di Renzo N, Olivieri A, Bocchia M, Gentile M, Marchesi F, Musto P, Federici AB, Candoni A, Venditti A, Fava C, Pinto A, Galieni P, Rigacci L, Armiento D, Pane F, Oberti M, Zappasodi P, Visco C, Franchi M, Grossi PA, Bertù L, Corrao G, Pagano L, Corradini P; ITA-HEMA-COV Investigators.
2020 Hematological oncology  Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma Irene Della Starza, Lucia Anna De Novi, Marzia Cavalli, Noemi Novelli, Roberta Soscia, Elisa Genuardi, Barbara Mantoan, Daniela Drandi, Martina Ferrante, Luigia Monitillo, Daniela Barbero, Elena Ciabatti, Susanna Grassi, Riccardo Bomben, Massimo Degan, Valter Gattei, Sara Galimberti, Alice Di Rocco, Maurizio Martelli, Sergio Cortelazzo, Anna Guarini, Robin Foà, Marco Ladetto, Simone Ferrero, Ilaria Del Giudice, Fondazione Italiana Linfomi (FIL) MRD Network
2020 Leukemia Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study
2020 Blood Marrow Transplant Stem Cell Mobilization After Bendamustine in Indolent Lymphomas: A Multicenter Study on Behalf of the Fondazione Italiana Linfomi Michele Merli , Stefano Luminari, Lucia Farina, Federica Cocito, Irene Defrancesco, Guido Gini, Annalisa Arcari, Greta Scapinello, Massimo Gentile, Maria Goldaniga, Giacomo Loseto, Emanuele Cencini, Antonino Greco, Anna Lia Molinari, Andrea Ferrario, Benedetta Bianchi, Barbara Mora, Lorenza Bertù, Vincenzo Saturni, Fabio Bergamini, Nicole Fabbri, Francesca Gaia Rossi, Silvia Bolis, Francesco Passamonti, Luca Arcaini.
2020  The Lancet Haematology Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project. Fox CP, Civallero M, Ko YH, Manni M, Skrypets T, Pileri S, Kim SJ, Cabrera ME, Shustov AR, Chiattone CS, Horwitz SM, Dlouhy I, Spina M, Hitz F, Montoto S, Nagler A, Martinez V, De Souza CA, Fernandez-Alvarez R, Ballova V, Gabús R, Inghirami G, Federico M, Kim WS.
2020 Radiation Oncology Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin’s lymphoma involving the mediastinum. Filippi AR, Meregalli S, DI Russo A, Levis M, Ciammella P, Buglione M, Guerini AE, De Marco G, De Sanctis V, Vagge S, Ricardi U, Simontacchi G; Fondazione Italiana Linfomi (FIL) Radiotherapy Committee.
2020 Tumori Journal  Management of lymphoma survivor patients in Italy: an evaluation by Fondazione Italiana Linfomi Minoia C, Bari A, Nassi L, Banzi R, Gerardi C, Lenti V, Calabrese M, Spina M, Guarini A.
2020 Haematologica Brentuximab Vedotin In The Treatment Of Elderly Hodgkin Lymphoma Patients At First Relapse Or With Primary Refractory Disease: A Phase 2 Study Of FIL ONLUS Stefoni V, Marangon M, Re A, Lleshi A, Bonfichi M, Pinto A, Bianchetti N, Pellegrini C, Argnani L, Zinzani PL.
2019 Annals of hematology The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of Pet-guided treatments Bari A, Marcheselli R, Sacchi S, Re A, Pagani C, Tucci A, Botto B, Vitolo U, Molinari AL, Puccini B, Pulsoni A, Santoro A, Tani M, Nassi L, Meli E, Pavone V, Bonfichi M, Evangelista A, Gioia D, Levis A, Zinzani P; Fondazione Italiana Linfomi (Onlus).
2019 The Lancet Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial Poeschel V, Held G , Ziepert M, Witzens-Harig M, Holte H, Thurner L, Borchmann P, Viardot A, Soekler M, Keller U, Schmidt C, Truemper L, Mahlberg R, Marks R, Hoeffkes HG, Metzner B, Dierlamm J, Frickhofen N, Haenel M, Neubauer A, Kneba M, Merli F, Tucci A, de Nully Brown P, Federico M, Lengfelder E, di Rocco A, Trappe R, Rosenwald A, Berdel C, Maisenhoelder M, Shpilberg O, Amam J, Christofyllakis K, Hartmann F, Murawski N, Stilgenbauer S, Nickelsen M, Wulf G, Glass B, Schmitz N, Altmann B, Loeffler M, Pfreundschuh M; FLYER Trial Investigators; German Lymphoma Alliance.
2019 Blood Cancer J First salvage treatment with bendamustine and brentuximab vedotin in Hodgkin lymphoma: a phase 2 study of the Fondazione Italiana Linfomi. Broccoli A, Argnani L, Botto B, Corradini P, Pinto A, Re A, Vitolo U, Fanti S, Stefoni V, Zinzani PL; Fondazione Italiana Linfomi ONLUS.
2019 Edizione Minerva Medica Second neoplasm in cutaneous T-cell lymphoma patients: a marker of worse prognosis? Pileri A, Guglielmo A, Fuligni F, Lastrucci I, Patrizi A, Pimpinelli N; Lymphoma Italian Foundation (Fondazione Italiana Linfomi, FIL), Cutaneous Lymphoma Task Force (Commissione Linfomi Cutanei).
2019 American journal of hematology Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas Francine M. Foss  Steven M. Horwitz  Monica Civallero  Monica Bellei  Luigi Marcheselli  Won Seog Kim  Maria E. Cabrera  Ivan Dlouhy  Arnon Nagler  Ranjana H. Advani  Emanuela A. Pesce  Young‐Hyeh Ko  Silvia Montoto  Carlos Chiattone  Alison Moskowitz  Michele Spina  Marina Cesaretti  Irene Biasoli  Massimo Federico
2019 Hemasphere MYC Rearranged Aggressive B-Cell Lymphomas: a report on 100 patients of the Fondazione Italiana Linfomi (FIL), Hemasphere Maria Chiara Tisi, Simone Ferrero,Irene Dogliotti,Cristina Tecchio,Giuseppe Carli, Mattia Novo, Piero Maria Stefani, Sara Rattotti, Monica Balzarotti, Dario Marino, Matteo Pelosini, Alessandra Romano, Leonardo Flenghi, Vittorio Ruggero Zilioli, Teresa Calimeri, Arianna Di Napoli, Manuela Zanni, Erica Finolezzi, Federico Mosna, Guido Gini, Giovanna Mansueto, Alice Di Rocco, Gabriella Tomei, Nicola Sgherza, Jacopo Olivieri, Luca Nassi, Francesco Piazza, Angelo Fama, Antonio Greco, Margherita Giannoccaro, Anna Maria Mazzone, Carlo Visco, Giacomo Loseto, and Francesco Zaja, on behalf of the Fondazione Italiana Linfomi Postgraduate Master course
2019 Haematologica KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study. Ferrero S, Rossi D, Rinaldi A, Bruscaggin A, Spina V, Eskelund CW, Evangelista A, Moia R, Kwee I, Dahl C, Di Rocco A, Stefoni V, Diop F, Favini C, Ghione P, Mahmoud AM, Schipani M, Kolstad A, Barbero D, Novero D, Paulli M, Zamò A, Jerkeman M, Gomez da Silva M, Santoro A, Molinari A, Ferreri A, Grønbæk K, Piccin A, Cortelazzo S, Bertoni F, Ladetto M, Gaidano G
2019 JCO Clinical Cancer Informatics  Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes. Zaccaria GM, Ferrero S, Rosati S, Ghislieri M, Genuardi E, Evangelista A, Sandrone R, Castagneri C, Barbero D, Lo Schirico M, Arcaini L, Molinari AL, Ballerini F, Ferreri A, Omedè P, Zamò A, Balestra G, Boccadoro M, Cortelazzo S, Ladetto M.
2019 Hematological oncology Minimal residual disease (MRD) in non‐Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network Della Starza I, Cavalli M, De Novi LA, Genuardi E, Mantoan B, Drandi D, Barbero D, Ciabatti E, Grassi S, Gazzola A, Mannu C, Agostinelli C, Piccaluga PP, Bomben R, Degan M, Gattei V, Guarini A, Foà R, Galimberti S, Ladetto M, Ferrero S, Del Giudice I; Fondazione Italiana Linfomi (FIL) MRD Network.
2019 British journal of haematology Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL) Rusconi C., Anastasia A., Chiarenza A., Marcheselli L., Cavallo F., Rattotti S., Botto B., Ferrari A., Nassi L., Pagani C., Meli E., Arcaini L., Federico M., Rossi G.
2019 JEADV Bexarotene as maintenance treatment after other than skin-directed therapy in advanced stage mycosis fungoides: a pilot study Pileri A., Fava P., Fuligni F., Gunnella S., Guglielmo A., Astrua C., Grandi V., Simontacchi G., Patrizi A., Quaglino P., Pimpinelli N.
2019 Journal of geriatric oncology Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi Merli F., Cavallo F., Salvi F., Tucci A., Musuraca G., Nassi L., Merli M., Tani M., Gini G., Ferrari A., Molinari A.L., Liberati A.M., Conconi A., Matteucci P., Bari A., Scalone R., Ferrero S., Zanni M., Mammi C., Luminari S.
2019 Blood Cancer J Early Progression As a Predictor of Survival in Marginal Zone Lymphomas: An Analysis from the FIL-NF10 Study Luminari S., Merli M., Rattotti S., Tarantino V., Marcheselli L., Cavallo F., Varettoni M., Bianchi B,, Merli F, Tedeschi A, Cabras G, Re F, Visco C., Delamain M.T., Cencini E., Spina M., Ferrero S., Ferrari A., Deodato M., Mannina D., Annibali O., Rago A., Orsucci L., Defrancesco I., Frigeni M., Cesaretti M., Arcaini L.
2019 Leukemia & Lymphoma Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL) Salvi F., Luminari S., Tucci A., Massidda S., Liberati A.M., Stelitano C., Zanni M., Re A., Centurioni R., Freilone R., Musuraca G., Nassi L., Patti C., Arcari A., Tani M., Pulsoni A., Pavone V., Volpetti S., Peli A., Evangelista A., Spina M., Ladetto M., Merli F.
2019 Giornale italiano di dermatologia e venereologia Primary cutaneous CD8+ CD30+ lymphoproliferative disorder in a patient with acquired CD4 immunodeficiency Pileri A., Gunnella S., Grandi V., Maio V., Santucci M., Pimpinelli N.
2019 British journal of haematology Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death Carlo Visco, Maria C Tisi, Andrea Evangelista, Alice Di Rocco, Anna-Katharina Zoellner, Vittorio R Zilioli, Stefan Hohaus, Roberta Sciarra, Alessandro Re, Cristina Tecchio, Annalisa Chiappella, Lucia Morello, Guido Gini, Luca Nassi, Tommasina Perrone, Anna L Molinari, Alberto Fabbri, Maria C Cox, Erica Finolezzi, Simone Ferrero, Benedetta Puccini, Isabel Alvarez De Celis, Annalisa Arcari, Dario Marino, Michele Merli, Francesco Piazza, Massimo Gentile, Matteo Pelosini, Giacomo Loseto, Olivier Hermine, Martin Dreyling, Marco Ruggeri, Maurizio Martelli, Eva Hoster, Umberto Vitolo, Fondazione Italiana Linfomi and the Mantle Cell Lymphoma Network
2018 Journal of the European Academy of Dermatology and Venereology (JEADV) Standardization of regimens in Narrowband UVB and PUVA in early stage mycosis fungoides: position paper from the Italian Task Force for Cutaneous Lymphomas Grandi V, Fava P, Rupoli S, Alberti Violetti S, Canafoglia L, Quaglino P, Berti E, Pimpinelli N; Cutaneous Lymphoma Task Force (Commissione Linfomi Cutanei) of Lymphoma Italian Foundation (Fondazione Italiana Linfomi, FIL)
2018 Leukemia Lymphoma Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi Francesco Zaja, Flavia Salvi, Maura Rossi, Elena Sabattini, Andrea Evangelista, Giovannino Ciccone, Emanuele Angelucci, Gianluca Gaidano, Manuela Zanni, Marco Ladetto, Annalisa Chiappella, Umberto Vitolo, Pier Luigi Zinzani, Catello Califano, Alessandra Tucci, Caterina Patti, Stefano A Pileri, Valentina Lenti, Pier Paolo Piccaluga, Federica Cavallo, Stefano Volpetti, Giulia Perali, Sarit Assouline, Koren Kathleen Mann, Ryan Morin, Miguel Alcaide, Kevin Bushell, Renato Fanin, Alessandro Levis
2018 Haematologica Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi Sergio Storti, Michele Spina, Emanuela Anna Pesce, Flavia Salvi, Michele Merli, Alessia Ruffini, Giuseppina Cabras, Annalisa Chiappella, Emanuele Angelucci, Alberto Fabbri, Anna Marina Liberati, Monica Tani, Gerardo Musuraca, Annalia Molinari, Maria Pia Petrilli, Carmela Palladino, Rosanna Ciancia, Andrea Ferrario, Cristiana Gasbarrino, Federico Monaco, Vincenzo Fraticelli, Annalisa De Vellis, Francesco Merli, Stefano Luminari
2018 Giornale italiano di dermatologia e venereologia Clinical and histological evaluation in patients with mycosis fungoides treated with UVA1. Trovato E, Pellegrino M, Filippi F, Mancini V, Pimpinelli N, Fimiani M.
2018 Blood Cancer J
CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies.
Ayed AO, Chiappella A, Pederson L, Laplant BR, Congiu AG, Gaidano G, Spina M, Re A, Cavallo F, Musuraca G, Macon WR, Witzig T, Vitolo U, Nowakowski GS
2018 JEADV Molecular genetic analyses of human endogenous retroviral elements belonging to the HERV-P and HERV-R family in primary cutaneous T-cell lymphomas. Bergallo M, Fava P, Galliano I, Novelli M, Montanari P, Daprà V, Rassu M, Quaglino P, Fierro MT.
2018 Giornale italiano di dermatologia e venereologia Verrucous mycosis fungoides. G Ital Dermatol Venereol. La Placa M, Alessandrini A, Agostinelli C, Pileri A
2018 Journal of clinical oncology Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron EmissionTomography/Computed Tomography Scan After Two ABVD Cycles: Long-TermResults of the GITIL/FIL HD 0607 Trial. Gallamini A, Tarella C, Viviani S, Rossi A, Patti C, Mulé A, Picardi M, Romano A, Cantonetti M, La Nasa G, Trentin L, Bolis S, Rapezzi D, Battistini R, Gottardi D, Gavarotti P, Corradini P, Cimminiello M, Schiavotto C, Parvis G, Zanotti R, Gini G, Ferreri AJM, Viero P, Miglino M, Billio A, Avigdor A, Biggi A, Fallanca F, Ficola U, Gregianin M, Chiaravalloti A, Prosperini G, Bergesio F, Chauvie S, Pavoni C, Gianni AM, Rambaldi A.
2018 JEADV Primary cutaneous small/medium-sized pleomorphic T-cell lymphoproliferative disorder shows a common vascular pattern at dermoscopy. J Eur Acad Dermatol Venereol Pileri A, Agostinelli C, Gaspari V, Leuzzi M, Sabattini E, Patrizi A, Savoia F
2018 Haematologica A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial. Bomben R, Ferrero S, D’Agaro T, Dal Bo M, Re A, Evangelista A, Carella AM, Zamò A, Vitolo U, Omedè P, Rusconi C, Arcaini L, Rigacci L, Luminari S, Piccin A, Liu D, Wiestner A, Gaidano G, Cortelazzo S, Ladetto M, Gattei V.
2018 Giornale italiano di dermatologia e venereologia Results of radiotherapy in minimal stage mycosis fungoides: a reappraisal after ten years. G Ital Dermatol Venereol Esposito L, Piccinno R, Marchese L, Berti E.
2018 JEADV Primary cutaneous peripheral T-cell lymphoma not otherwise specified: a rare and aggressive lymphoma. J Eur Acad Dermatol Venereol. Pileri A, Agostinelli C, Fuligni F, Broccoli A, Gunnella S, Sabattini E, Grandi V, Guglielmo A, Zinzani PL, Patrizi A, Pimpinelli N.
2018 Cancer immunology and immunotherapy The role of myeloid derived suppressor cells in mycosis fungoides. Cancer Immunol Immunother Pileri A, Agostinelli C, Quaglino P, Patrizi A, Pimpinelli N.
2018 Giornale italiano di dermatologia e venereologia Alopecia areata-like mycosis fungoides: lions for lambs. G Ital Dermatol Venereol. Pileri A, Agostinelli C, Bruni F, Grandi V, Alessandrini A, Pimpinelli N, Piraccini BM.
2018 European Journal of Cancer Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force. Eur J Cancer. Scarisbrick JJ, Hodak E, Bagot M, Stranzenbach R, Stadler R, Ortiz-Romero PL, Papadavid E, Evison F, Knobler R, Quaglino P, Vermeer MH.
2018 European Journal of Cancer Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma. El-Galaly TC, Cheah CY, Bendtsen MD, Nowakowski GS, Kansara R, Savage KJ, Connors JM, Sehn LH, Goldschmidt N, Shaulov A, Farooq U, Link BK, Ferreri AJM, Calimeri T, Cecchetti C, Dann EJ, Thompson CA, Inbar T, Maurer MJ, Gade IL, Juul MB, Hansen JW, Holmberg S, Larsen TS, Cordua S, Mikhaeel NG, Hutchings M, Seymour JF, Clausen MR, Smith D, Opat S, Gilbertson M, Thanarajasingam G, Villa D.
2018 Leukemia & lymphoma. Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi. Zaja F, Salvi F, Rossi M, Sabattini E, Evangelista A, Ciccone G, Angelucci E, Gaidano G, Zanni M, Ladetto M, Chiappella A, Vitolo U, Zinzani PL, Califano C, Tucci A, Patti C, Pileri SA, Lenti V, Piccaluga PP, Cavallo F, Volpetti S, Perali G, Assouline S, Mann KK, Morin R, Alcaide M, Bushell K, Fanin R, Levis A.
2018 Oncotarget Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma. Broccoli A, Casadei B, Morigi A, Sottotetti F, Gotti M, Spina M, Volpetti S, Ferrero S, Spina F, Pisani F, Merli M, Visco C, Paolini R, Zilioli VR, Baldini L, Di Renzo N, Tosi P, Cascavilla N, Molica S, Ilariucci F, Rigolin GM, D’Alò F, Vanazzi A, Santambrogio E, Marasca R, Mastrullo L, Castellino C, Desabbata G, Scortechini I, Trentin L, Morello L, Argnani L, Zinzani PL.
2018 Oncologist Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study). Stefoni V, Pellegrini C, Broccoli A, Baldini L, Tani M, Cencini E, Figuera A, Ansuinelli M, Bernocco E, Cantonetti M, Cox MC, Ballerini F, Rusconi C, Visco C, Arcaini L, Fama A, Marasca R, Volpetti S, Castellino A, Califano C, Cavaliere M, Gini G, Liberati AM, Musuraca G, Lucania A, Ricciuti G, Argnani L, Zinzani PL
2018 Haematologica Rituximab plus Bendamustine as front line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin’s lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi (FIL) Sergio Storti, Michele Spina, Emanuela Anna Pesce, Flavia Salvi, Michele Merli, Alessia Ruffini, Giuseppina Cabras, Annalisa Chiappella, Emanuele Angelucci, Alberto Fabbri, Anna Marina Liberati, Monica Tani, Gerardo Musuraca, Annalia Molinari, Maria Pia Petrilli, Carmela Palladino, Rosanna Ciancia, Andrea Ferrario, Cristiana Gasbarrino, Federico Monaco, Vincenzo Fraticelli, Annalisa De Vellis, Francesco Merli and Stefano Luminari
2018 Biol Blood Marrow Transplant A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi Olivieri J, Mosna F, Pelosini M, Fama A, Rattotti S, Giannoccaro M, Carli G, Tisi MC, Ferrero S, Sgherza N, Mazzone AM, Marino D, Calimeri T, Loseto G, Saraceni F, Tomei G, Sica S, Perali G, Codeluppi K, Billio A, Olivieri A, Orciuolo E, Matera R, Stefani PM, Borghero C, Ghione P, Cascavilla N, Lanza F, Chiusolo P, Finotto S, Federici I, Gherlinzoni F, Centurioni R, Fanin R, Zaja F; Fondazione Italiana Linfomi Postgraduate Master Course.
2018 Anticancer Research DNA from Human Polyomaviruses, MWPyV, HPyV6, HPyV7, HPyV9 and HPyV12 in Cutaneous T-cell Lymphomas Bergallo M, Daprà V, Fava P, Ponti R, Calvi C, Montanari P, Novelli M, Quaglino P, Galliano I, Fierro MT.
2018 Ann Oncol Progression-Free Survival at 24 Months (PFS24) and Subsequent Outcome For Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Enrolled On Randomized Clinical Trials. Maurer MJ,Habermann TM, Shi Q, Schmitz N, Cunningham D, Pfreundschuh M, Seymour JF, Jaeger U, Haioun C, Tilly H, Ghesquieres H, Merli F, Ziepert M, Herbrecht R, Flament J, Fu T, Flowers CR, Coiffier B.
2018 Lancet Haematol Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis. Federico M, Caballero Barrigón MD, Marcheselli L, Tarantino V, Manni M, Sarkozy C, Alonso-Álvarez S, Wondergem M, Cartron G, Lopez-Guillermo A, Issa D, Morschhauser F, Alcoceba M, Kimby E, Rusconi C, Chamuleau M, Holte H, Lockmer S, Montoto S, Gomes da Silva M, Aurer I, Zucca E, Paszkiewicz-Kozik E, Minoia C, Skrypets T, Blaker YN, Salles G, Coiffier B; Aristotle Consortium.
2018 British journal of haematology. High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO. Avivi I, Arcaini L, Ferretti VV, Boumendil A, Finel H, Milone G, Zaja F, Liliana D, Musso M, Didier B, Bachy E, Wattad M, Nicolas-Virelizier E, Gramatzki M, Bourhis JH, Caillot D, Haenel A, Held G, Thieblemont C, Jindra P, Pohlreich D, Guilhot F, Kroschinsky F, Wahlin B, Scheid C, Ifrah N, Berthou C, Dreger P, Montoto S, Conconi A.
2018 Annals of Oncology Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium. Ann Oncol. Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y.
2018 J Clin Oncol.
Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL).
Shi Q, Schmitz N, Ou FS, Dixon JG, Cunningham D, Pfreundschuh M, Seymour JF, Jaeger U, Habermann TM, Haioun C, Tilly H, Ghesquieres H, Merli F, Ziepert M, Herbrecht R, Flament J, Fu T, Coiffier B, Flowers CR.
2018 European Journal of Cancer Developments in the understanding of blood involvement and stage in mycosis fungoides/Sezary syndrome. Scarisbrick JJ, Hodak E, Bagot M, Stranzenbach R, Stadler R, Ortiz-Romero PL, Papadavid E, Knobler R, Quaglino P, Vermeer M
2018 American journal of hematology Rituximab, Bendamustine and Cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma. Tisi MC, Paolini R, Piazza F, Ravelli E, Tecchio C, Sartori R, Famengo B, D’Amore ESG, Carli G, Perbellini O, Di Bona E, Ruggeri M, Visco C.
2018 Modern Pathology Transcriptional analysis distinguishes breast implant-associated anaplastic large cell lymphoma from other peripheral T-cell lymphomas. Mod Pathol. Di Napoli A, De Cecco L, Piccaluga PP, Navari M, Cancila V, Cippitelli C, Pepe G, Lopez G, Monardo F, Bianchi A, D’Amore ESG, Gianelli U, Facchetti F, Berti E, Bhagat G.
2018 British journal of Dermatology The PROCLIPI international registry of early stage Mycosis Fungoides identifies substantial diagnostic delay in most patients Scarisbrick JJ, Quaglino P, Prince HM, Papadavid E, Hodak E, Bagot M, Servitje O, Berti E, Ortiz-Romero P, Stadler R, Patsatsi A, Knobler R, Guenova E, Nikolaou V, Tomasini C, Amitay I, Prag Naveh H, Ram-Wolff C, Battistella M, Alberti-Violetti S, Stranzenbach R, Gargallo V, Muniesa C, Koletsa T, Jonak C, Porkert S, Mitteldorf C, Estrach T, Combalia A, Marschalko M, Csomor J, Szepesi A, Cozzio A, Dummer R, Pimpinelli N, Grandi V, Beylot-Barry M, Pham-Ledard A, Wobser M, Geissinger E, Wehkamp U, Weichenthal M, Cowan R, Parry E, Harris J, Wachsmuth R, Turner D, Bates A, Healy E, Trautinger F, Latzka J, Yoo J, Vydianath B, Amel-Kashipaz R, Marinos L, Oikonomidi A, Stratigos A, Vignon-Pennamen MD, Battistella M, Climent F, Gonzalez-Barca E, Georgiou E, Senetta R, Zinzani P, Vakeva L, Ranki A, Busschots AM, Hauben E, Bervoets A, Woei-A-Jin FJSH, Matin R, Collins G, Weatherhead S, Frew J, Bayne M, Dunnill G, McKay P, Arumainathan A, Azurdia R, Benstead K, Twigger R, Rieger K, Brown R, Sanches JA, Miyashiro D, Akilov O, McCann S, Sahi H, Damasco FM, Querfeld C, Folkes A, Bur C, Klemke CD, Enz P, Pujol R, Quint K, Geskin L, Hong E, Evison F, Vermeer M, Cerroni L, Kempf W, Kim Y, Willemze R.
2018 Giornale italiano di dermatologia e venereologia Italian Lymphoma Foundation. Real-life use of phototherapy in early-stage mycosis fungoides from the Cutaneous Lymphoma Commission of the Italian Lymphoma Foundation: results of a web-based survey. G Ital Dermatol Venereol. Grandi V, Fava P, Rupoli S, Alberti Violetti S, Canafoglia L, Berti E, Quaglino P, Pimpinelli N
2018 JEADV Standardization of regimens in Narrowband UVB and PUVA in early stage mycosis fungoides: position paper from the Italian Task Force for Cutaneous Lymphomas. J Eur Acad Dermatol Venereol. Grandi V, Fava P, Rupoli S, Alberti Violetti S, Canafoglia L, Quaglino P, Berti E, Pimpinelli N; Cutaneous Lymphoma Task Force (Commissione Linfomi Cutanei) of Lymphoma Italian Foundation (Fondazione Italiana Linfomi, FIL).
2017 Critical reviews in oncology/hematology Primary mediastinal large B-cell lymphoma. Martelli M, Ferreri A, Di Rocco A, Ansuinelli M, Johnson PWM
2017 Expert review of hematology Is now the time for molecular driven therapy for diffuse large B-cell lymphoma? Di Rocco A, De Angelis F, Ansuinelli M, Foà R, Martelli M
2017 Journal of clinical oncology Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisonein Previously Untreated Diffuse Large B-Cell Lymphoma. Vitolo U, Trněný M, Belada D, Burke JM, Carella AM, Chua N, Abrisqueta P, Demeter J, Flinn I, Hong X, Kim WS, Pinto A, Shi YK, Tatsumi Y, Oestergaard MZ, Wenger M, Fingerle-Rowson G, Catalani O, Nielsen T, Martelli M, Sehn LH.
2017 British journal of haematology Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18-FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 study. Ceriani L, Martelli M, Conconi A, Zinzani PL, Ferreri AJM, Botto B, Stelitano C, Gotti M, Cabras MG, Rigacci L, Giovanella L, Zucca E, Johnson PWM.
2017 The Lancet Oncology Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study. Chiappella A, Martelli M, Angelucci E, Brusamolino E, Evangelista A, Carella AM, Stelitano C, Rossi G, Balzarotti M, Merli F, Gaidano G, Pavone V, Rigacci L, Zaja F, D’Arco A, Cascavilla N, Russo E, Castellino A, Gotti M, Congiu AG, Cabras MG, Tucci A, Agostinelli C, Ciccone G, Pileri SA, Vitolo U.
2017 British journal of haematology Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1-2 study. Cascione L., Rinaldi A., Chiappella A., Kwee I., Ciccone G., Altenbuchinger M., Kohler C., Vitolo U., Inghirami G., Bertoni F.
2017 Annals of hematology Role of bone marrow biopsy in staging of patients with classical Hodgkin’s lymphoma undergoing positron emission tomography/computed tomography. Puccini B, Nassi L, Minoia C, Volpetti S, Ciancia R, Riccomagno PC, Di Rocco A, Mulè A, Toldo C, Sassone MC, Guariglia R, Filì C, Finolezzi E, Falorio S, Zanon S, Furlan A, Doa G, Zaja F
2017 Journal of clinical oncology Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy. Zucca E, Conconi A, Martinelli G, Bouabdallah R, Tucci A, Vitolo U, Martelli M, Pettengell R, Salles G, Sebban C, Guillermo AL, Pinotti G, Devizzi L, Morschhauser F, Tilly H, Torri V, Hohaus S, Ferreri AJM, Zachée P, Bosly A, Haioun C, Stelitano C, Bellei M, Ponzoni M, Moreau A, Jack A, Campo E, Mazzucchelli L, Cavalli F, Johnson P, Thieblemont C.
2017 Journal of clinical oncology Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial. André MPE, Girinsky T, Federico M, Reman O, Fortpied C, Gotti M, Casasnovas O, Brice P, van der Maazen R, Re A, Edeline V, Fermé C, van Imhoff G, Merli F, Bouabdallah R, Sebban C, Specht L, Stamatoullas A, Delarue R, Fiaccadori V, Bellei M, Raveloarivahy T, Versari A, Hutchings M, Meignan M, Raemaekers J.
2017 Hematological oncology Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi. Luminari S, Viel E, Ferreri AJM, Zaja F, Chimienti E, Musuraca G, Tucci A, Balzarotti M, Tani M, Salvi F, Pesce EA, Ferrari A, Liberati AM, Spadea A, Marino D, Bruno-Ventre M, Volpetti S, Bottelli C, Ravaioli E, Merli F, Spina M.
2017 Haematologica Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi. Zaja F, Ferrero S, Stelitano C, Ferrari A, Salvi F, Arcari A, Musuraca G, Botto B, Spina M, Cellini C, Patti C, Liberati AM, Minotto C, Pileri SA, Ceccarelli M, Volpetti S, Ferranti A, Drandi D, Montechiarello E, Ladetto M, Carmichael J, Fanin R.
2017 Thrombosis and haemostasis Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas. A pooled-data analysis of 12 clinical trials of Fondazione Italiana Linfomi (FIL). Santi RM, Ceccarelli M, Bernocco E, Monagheddu C, Evangelista A, Valeri F, Monaco F, Vitolo U, Cortelazzo S, Cabras MG, Spina M, Baldini L, Boccomini C, Chiappella A, Bari A, Luminari S, Visco C, Calabrese M, Limberti G, Levis A, Contino L, Ciccone G, Ladetto M.
2017 Blood Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial. Zinzani PL., Pellegrini C., Chiappella A., Di Rocco A., Salvi F., Cabras MG., Argnani L., Stefoni V.
2017 Thrombosis research PO-03 – Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL). Santi RM, Ceccarelli M, Catania G, Monagheddu C, Evangelista A, Bernocco E, Monaco F, Federico M, Vitolo U, Cortelazzo S, Cabras MG, Spina M, Baldini L, Boccomini C, Chiappella A, Bari A, Luminari S, Calabrese M, Levis A, Visco C, Contino L, Ciccone G, Ladetto M.
2017 The Lancet Haematology Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial. Ferreri AJ, Sassone M, Zaja F, Re A, Spina M, Di Rocco A, Fabbri A, Stelitano C, Frezzato M, Rusconi C, Zambello R, Couto S, Ren Y, Arcari A, Bertoldero G, Nonis A, Scarfò L, Calimeri T, Cecchetti C, Chiozzotto M, Govi S, Ponzoni M.
2017 International journal of radiation oncology, biology, physics Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma. Ceriani L., Martelli M., Gospodarowicz MK., Ricardi U., Ferreri AJ., Chiappella A., Stelitano C., Balzarotti M., Cabrera ME., Cunningham D., Guarini A., Zinzani PL., Giovanella L., Johnson PW., Zucca E.
2017 The Lancet Haematology Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi. Carlo Visco, Annalisa Chiappella, Luca Nassi, Caterina Patti, Simone Ferrero, Daniela Barbero, Andrea Evangelista, Michele Spina, Annalia Molinari, Luigi Rigacci, Monica Tani, Alice Di Rocco, Graziella Pinotti, Alberto Fabbri, Renato Zambello, Silvia Finotto, Manuel Gotti, Angelo M Carella, Flavia Salvi, Stefano A Pileri, Marco Ladetto, Giovannino Ciccone, Gianluca Gaidano, Marco Ruggeri, Maurizio Martelli, Umberto Vitolo
2017 American Journal of Hematology CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell AQ1 lymphoma: Possible biomarkers for novel targeted therapies? Francesco Zaja, Valentina Tabanelli, Claudio Agostinelli, Angelica Calleri, Annalisa Chiappella, Marzia Varettoni, Pier Luigi Zinzani, Stefano Volpetti, Elena Sabattini, Renato Fanin, Stefano Aldo Pileri
2016 British journal of haematology Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL). Zallio F., Tamiazzo S., Monagheddu C., Merli F., Ilariucci F., Stelitano C., Liberati AM., Mannina D.,Vitolo U., Angelucci E., Rota Scalabrini D., Vallisa D., Bellei M., Bari A., Ciccone G., Salvi F., Levis A.
2016 Haematologica Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi. Luminari S, Galimberti S, Versari A, Biasoli I, Anastasia A, Rusconi C, Ferrari A, Petrini M, Manni M, Federico M.
2016 Leukemia & lymphoma A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma. Luminari S, Goldaniga M, Cesaretti M, Orsucci L, Tucci A, Pulsoni A, Salvi F, Arcaini L, Carella AM, Tedeschi A, Pinto A, Stelitano C, Baldini L.
2016 Haematologica Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi. Sacchi S., Marcheselli R., Bari A., Buda G., Molinari AL., Baldini L., Vallisa D., Cesaretti M., Musto P.,Ronconi S., Specchia G., Silvestris F., Guardigni L., Ferrari A, Chiapella A., Carella AM., Santoro A., Di Raimondo F., Marcheselli L., Pozzi S.
2016 Leukemia & lymphoma A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma. Stefano Luminari, Maria Goldaniga, Marina Cesaretti, Lorella Orsucci, Alessandra Tucci, Alessandro Pulsoni, Flavia Salvi, Luca Arcaini, Angelo Michele Carella, Alessandra Tedeschi, Antonello Pinto, Caterina Stelitano and Luca Baldini
2016 Leukemia & lymphoma B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of theFondazione Italiana Linfomi (FIL). Balzarotti M, Brusamolino E, Angelucci E, Carella AM, Vitolo U, Russo E, Congiu A, Gotti M, Massidda S, Botto B, Annechini G, Spina M, Re A, Zilioli VR, Merli F, Salvi F, Stelitano C, Bonfichi M, Rodari M, Murru R, Magagnoli M1, Anastasia A, Mazza R, Giordano L,Santoro A.
2016 Journal of clinical oncology Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study. Zinzani PL, Broccoli A, Gioia DM, Castagnoli A, Ciccone G, Evangelista A, Santoro A, Ricardi U, Bonfichi M, Brusamolino E, Rossi G, Anastasia A, Zaja F, Vitolo U, Pavone V, Pulsoni A, Rigacci L, Gaidano G, Stelitano C, Salvi F, Rusconi C, Tani M, Freilone R, Pregno P, Borsatti E,Sacchetti GM, Argnani L, Levis A.
2016 Leukemia & lymphoma Alternative options for elderly patients with limited stage diffuse large B-cell lymphoma: R-chemotherapy vs. R-chemotherapy plus radiotherapy Patrizia Ciammella, Andrea Riccardo Filippi, Gabriele Simontacchi, Michela Buglione, Carlo Furlan, Michele Spina, Alessandra Tucci, Luigi Rigacci, Cinzia Iotti, Umberto Vitolo, Umberto Ricardi and Francesco Merli
2016 British journal of haematology Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients. Patrizia Ciammella, Andrea Riccardo Filippi, Gabriele Simontacchi, Michela Buglione, Barbara Botto, Monica Mangoni, Cinzia Iotti, Francesco Merli, Luigi Marcheselli, Gianni Bisi, Umberto Ricardi and Annibale Versari
2016 The Lancet. Haematology Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Ferreri AJ, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, Fox CP, Rosée PL, Schorb E, Ambrosetti A, Roth A, Hemmaway C, Ferrari A, Linton KM, Rudà R, Binder M, Pukrop T, Balzarotti M, Fabbri A, Johnson P, Gørløv JS, Hess G, Panse J, Pisani F, Tucci A, Stilgenbauer S, Hertenstein B, Keller U, Krause SW, Levis A, Schmoll HJ, Cavalli F, Finke J, Reni M, Zucca E, Illerhaus G; International Extranodal Lymphoma Study Group (IELSG).
2016 Thrombosis Research PO-03 – Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL). Santi RM, Ceccarelli M, Catania G, Monagheddu C, Evangelista A, Bernocco E, Monaco F, Federico M, Vitolo U,Cortelazzo S, Cabras MG, Spina M, Baldini L, Boccomini C, Chiappella A, Bari A, Luminari S, Calabrese M, Levis A, Visco C, Contino L, Ciccone G, Ladetto M.
2016 Journal of clinical oncology Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi. Merli F, Luminari S, Gobbi PG, Cascavilla N, Mammi C, Ilariucci F, Stelitano C, Musso M, Baldini L, Galimberti S, Angrilli F, Polimeno G, Scalzulli PR, Ferrari A, Marcheselli L, Federico M.
2016 Journal of hematology & oncology A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients. Pellegrini C, Dodero A, Chiappella A, Monaco F, Degl’Innocenti D, Salvi F, Vitolo U, Argnani L, Corradini P, Zinzani PL
2016 Future oncology ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma. Nowakowski GS, Chiappella A, Witzig TE, Spina M, Gascoyne RD, Zhang L, Flament J, Repici J, Vitolo U.
2016 Journal of clinical oncology Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study. Zinzani PL, Broccoli A, Gioia DM, Castagnoli A, Ciccone G, Evangelista A, Santoro A, Ricardi U, Bonfichi M, Brusamolino E, Rossi G, Anastasia A, Zaja F, Vitolo U, Pavone V, Pulsoni A, Rigacci L, Gaidano G, Stelitano C, Salvi F, Rusconi C, Tani M, Freilone R, Pregno P, Borsatti E, Sacchetti GM, Argnani L, Levis
2016 Physica Medica The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma). Chauvie S, Bergesio F, Fioroni F, Brambilla M, Biggi A, Versari A, Guerra L, Storto G, Musto P, Luminari S, Cabras MG, Balzarotti M, Rigacci L, Martelli M, Vitolo U, Federico M, Gallamini A.
2016 Haematologica Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi. Sacchi S, Marcheselli R, Bari A, Buda G, Molinari AL, Baldini L, Vallisa D, Cesaretti M, Musto P, Ronconi S, Specchia G, Silvestris F, Guardigni L, Ferrari A, Chiapella A, Carella AM, Santoro A, Di Raimondo F, Marcheselli L, Pozzi S.
2016 Leukemia & lymphoma The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study. Zinzani PL, Rigacci L, Cox MC, Devizzi L, Fabbri A, Zaja F, Di Rocco A, Rossi G, Storti S, Fattori PP, Argnani L, Vitolo U.
2016 Journal of chemotherapy Impressive and durable response in a case of multiple relapsed mantle cell lymphoma treated with bortezomib and rituximab. Cencini E, Guerrini S, Mazzei MA, Chiappella A, Fabbri A.
2016 Journal of clinical oncology Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study Armando Santoro, Rita Mazza, Alessandro Pulsoni, Alessandro Re, Maurizio Bonfichi, Vittorio Ruggero Zilioli, Flavia Salvi, Francesco Merli, Antonella Anastasia, Stefano Luminari, Giorgia Annechini, Manuel Gotti, Annalisa Peli, Anna Marina Liberati, Nicola Di Renzo, Luca Castagna, Laura Giordano, and Carmelo Carlo-Stella
2016 Hematological oncology Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B-cell lymphoma: interim analysis in the ongoing International Extranodal Lymphoma Study Group-37 study. Ceriani L, Barrington S, Biggi A, Malkowski B, Metser U, Versari A, Martelli M, Davies A, Johnson PW, Zucca E, Chauvie S.
2016 International journal of radiation oncology, biology, physics PET/CT assessment after immunochemotherapy and irradiation using the Lugano Classification criteria in the IELSG-26 study of primary mediastinal B-cell lymphoma L. Ceriani, M. Martelli, M.K. Gospodarowicz, U. Ricardi, A.J.M. Ferreri, U. Vitolo, C. Stelitano, M. Balzarotti, M.E. Cabrera, D.Cunningham, A. Guarini , P.L. Zinzani, L. Giovanella, P.W.M. Johnson, and E. Zucca.
2016 Journal of clinical oncology Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas. Cortelazzo S, Tarella C, Gianni AM, Ladetto M, Barbui AM, Rossi A, Gritti G, Corradini P, Di Nicola M, Patti C, Mulé A, Zanni M, Zoli V, Billio A, Piccin A, Negri G, Castellino C, Di Raimondo F, Ferreri AJ, Benedetti F, La Nasa G, Gini G, Trentin L, Frezzato M, Flenghi L, Falorio S, Chilosi M, Bruna R, Tabanelli V, Pileri S, Masciulli A, Delaini F, Boschini C, Rambaldi A.
2015 American journal of hematology The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi Rossi G1, Marcheselli L, Dondi A, Bottelli C, Tucci A, Luminari S, Arcaini L, Merli M, Pulsoni A, Boccomini C, Puccini B, Micheletti M, Martinelli G, Rossi A, Zilioli VR, Bozzoli V, Balzarotti M, Bolis S, Cabras MG, Federico M.
2015 Leukemia & lymphoma Comparison of different DNA extraction methods from peripheral blood cells: advice from the Fondazione Italiana Linfomi Minimal Residual Disease Network. Mannu C, Gazzola A, Ciabatti E, Fuligni F, Cavalli M, Della Starza I, Genuardi E, Mantoan B, Monitillo L, Del Giudice I, Ladetto M, Gaidano G, Sabattini E, Pileri SA, Galimberti S, Piccaluga PP; Fondazione Italiana Linfomi Minimal Residual Disease Network.
2015 Haematologica The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefitfrom doxorubicin: FIL-FOLL study. Rossi D, Bruscaggin A, La Cava P, Galimberti S, Ciabatti E, Luminari S, Rigacci L, Tucci A, Pulsoni A, Bertoldero G, Vallisa D, Rusconi C, Spina M, Arcaini L, Angrilli F, Stelitano C, Merli F, Gaidano G, Federico M, Palumbo GA
2015 Leukemia & lymphoma Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL). Tucci A, Martelli M, Rigacci L, Riccomagno P, Cabras MG, Salvi F, Stelitano C, Fabbri A, Storti S, Fogazzi S, Mancuso S, Brugiatelli M, Fama A, Paesano P, Puccini B, Bottelli C, Dalceggio D, Bertagna F, Rossi G, Spina M; Italian Lymphoma Foundation (FIL).
2015 British journal of haematology Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced-stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi. Marcheselli L1, Bari A, Anastasia A, Botto B, Puccini B, Dondi A, Carella AM, Alvarez I, Chiarenza A, Arcari A, Salvi F, Federico M.
2015 American journal of hematology The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentricstudy by the fondazione italiana linfomi (FIL). Rigacci L, Puccini B, Zinzani PL, Biggi A, Castagnoli A, Merli F, Balzarotti M, Stelitano C, Spina M, Vitolo U, Stefoni V, Levis A, Gotti M, Rosaria S, Maria SP, Bosi A, Gallamini A.
2015 Leukemia & lymphoma Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione ItalianaLinfomi phase II study. Iannitto E, Luminari S, Tripodo C, Mancuso S, Cesaretti M, Marcheselli L, Merli F, Stelitano C, Carella AM, Fragasso A, Montechiarello E, Ricciuti G, Pulsoni A, Paulli M, Franco V, Federico M.
2015 Oncologist Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41). Jackson AE, Mian M, Kalpadakis C, Pangalis GA, Stathis A, Porro E, Conconi A, Cortelazzo S, Gaidano G, Lopez Guillermo A, Johnson PW, Martelli M, Martinelli G, Thieblemont C, McPhail ED, Copie-Bergman C, Pileri SA, Jack A, Campo E, Mazzucchelli L, Ristow K, Habermann TM, Cavalli F, Nowakowski GS, Zucca E.
2015 Blood Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primarymediastinal (thymic) large B-cell lymphoma. Ceriani L, Martelli M, Zinzani PL, Ferreri AJ, Botto B, Stelitano C, Gotti M, Cabras MG, Rigacci L, Gargantini L, Merli F, Pinotti G, Mannina D, Luminari S, Stathis A, Russo E, Cavalli F, Giovanella L, Johnson PW, Zucca E.
2015 Practical radiation oncology Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma. Piva C, Genovesi D, Filippi AR, Balducci M, Barra S, Buglione M, Busetto M, Ciammella P, Franzone P, De Sanctis V, Simontacchi G, Fusella M, Ricardi U; Radiation Oncology Committee of the Italian Lymphoma Foundation (FIL).
2015 International journal of radiation oncology, biology, physics Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy. In Reply to Adams and Kwee. Simontacchi G, Filippi AR, Ciammella P, Ricardi U.
2015 Journal of clinical oncology Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial. Ferreri AJ, Donadoni G, Cabras MG, Patti C, Mian M2, Zambello R, Tarella C, Di Nicola M, D’Arco AM, Doa G, Bruno-Ventre M, Assanelli A, Foppoli M, Citterio G, Fanni A, Mulè A, Caligaris-Cappio F, Ciceri F
2015 Leukemia & lymphoma Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter study. Arcari A, Chiappella A, Spina M, Zanlari L, Bernuzzi P, Valenti V, Tani M, Marasca R, Cabras MG, Zambello R, Santagostino A, Ilariucci F, Carli G, Musto P, Savini P, Marino D, Ghio F, Gentile M, Cox MC, Vallisa D.
2014 Leukemia & lymphoma. Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi. Merli F, Luminari S, Rossi G, Mammi C, Marcheselli L, Ferrari A, Spina M, Tucci A, Stelitano C, Capodanno I, Fragasso A, Baldini L, Bottelli C, Montechiarello E, Fogazzi S, Lamorgese C, Cavalli L, Federico M; Fondazione Italiana Linfomi.
2014 Leukemia & lymphoma. Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma heldin Menton, France, 3-5 October 2012. Meignan M, Barrington S, Itti E, Gallamini A, Haioun C, Polliack A.
2014 Annals of oncology The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subsetanalysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL). Luminari S, Biasoli I, Versari A, Rattotti S, Bottelli C, Rusconi C, Merli F, Spina M, Ferreri AJ, Zinzani PL, Gallamini A, Franceschetto A, Boccomini C, Franceschetti S, Salvi F, Raimondo FD, Carella AM, Micol Q, Balzarotti M, Musto P, Federico M
2014 The New England journal of medicine. The role of myeloablation for lymphoma. Schmitz N, Ziepert M, Vitolo U; German High-Grade Non-Hodgkin’s Lymphoma Study Group; Fondazione Italiana Linfomi.
2014 Haematologica Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi Merli M, Visco C, Spina M, Luminari S, Ferretti VV, Gotti M, Rattotti S, Fiaccadori V, Rusconi C, Targhetta C, Stelitano C, Levis A, Ambrosetti A, Rossi D, Rigacci L, D’Arco AM, Musto P, Chiappella A, Baldini L, Bonfichi M, Arcaini L.
2014 Journal of clinical oncology Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkinlymphoma is associated with an increased risk of early relapse: Clinical results of the preplannedinterim analysis of the randomized EORTC/LYSA/FIL H10 trial. Raemaekers JM, André MP, Federico M, Girinsky T, Oumedaly R, Brusamolino E, Brice P, Fermé C, van der Maazen R, Gotti M, Bouabdallah R, Sebban CJ, Lievens Y, Re A, Stamatoullas A, Morschhauser F, Lugtenburg PJ, Abruzzese E, Olivier P, Casasnovas RO, van Imhoff G, Raveloarivahy T, Bellei M, van der Borght T, Bardet S, Versari A, Hutchings M, Meignan M, Fortpied C.
2014 The Lancet Oncology Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial. Vitolo U, Chiappella A, Franceschetti S, Carella AM, Baldi I, Inghirami G, Spina M, Pavone V, Ladetto M, Liberati AM, Molinari AL, Zinzani P, Salvi F, Fattori PP, Zaccaria A, Dreyling M, Botto B, Castellino A, Congiu A, Gaudiano M, Zanni M, Ciccone G, Gaidano G, Rossi G; Fondazione Italiana Linfomi.
2014 Journal of clinical oncology [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study. Martelli M, Ceriani L, Zucca E, Zinzani PL, Ferreri AJ, Vitolo U, Stelitano C, Brusamolino E, Cabras MG, Rigacci L, Balzarotti M, Salvi F, Montoto S, Lopez-Guillermo A, Finolezzi E, Pileri SA, Davies A, Cavalli F, Giovanella L, Johnson PW.
2014 Annals of oncology Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi Arcaini L, Vallisa D, Rattotti S, Ferretti VV, Ferreri AJ, Bernuzzi P, Merli M, Varettoni M, Chiappella A, Ambrosetti A, Tucci A, Rusconi C, Visco C, Spina M, Cabras G, Luminari S, Tucci M, Musto P, Ladetto M, Merli F, Stelitano C, d’Arco A, Rigacci L, Levis A, Rossi D, Spedini P, Mancuso S, Marino D, Bruno R, Baldini L, Pulsoni A.
2014 British journal of haematology Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation: a retrospective study of the Fondazione Italiana Linfomi Anastasia, A., Carlo-Stella, C., Corradini, P., Salvi, F., Rusconi, C., Pulsoni, A., Hohaus, S., Pregno, P., Viviani, S., Brusamolino, E., Luminari, S., Giordano, L., and Santoro A.
2014 Leukemia Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosedpatients with peripheral T-cell lymphoma. Corradini P, Vitolo U, Rambaldi A, Miceli R, Patriarca F, Gallamini A, Olivieri A, Benedetti F, Todeschini G, Rossi G, Salvi F, Bruno B, Baldini L, Ferreri A, Patti C, Tarella C, Pileri S, Dodero A.
2014 Journal of clinical oncology Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA; Alliance, Australasian Leukaemia and Lymphoma Group; Eastern Cooperative Oncology Group; European Mantle Cell Lymphoma Consortium; Italian Lymphoma Foundation; European Organisation for Research; Treatment of Cancer/Dutch Hemato-Oncology Group; Grupo Español de Médula Ósea; German High-Grade Lymphoma Study Group; German Hodgkin’s Study Group; Japanese Lymphorra Study Group; Lymphoma Study Association; NCIC Clinical Trials Group; Nordic Lymphoma Study Group; Southwest Oncology Group; United Kingdom National Cancer Research Institute.
2014 Journal of geriatric oncology The “Elderly Project” by The Fil (Fondazione Italiana Linfomi): A project aimed at the prospective multidimensional assessment of elderly patients with diffuse large B-cell lymphoma F. Merli, S. Luminari, A. Tucci, C. Mammi, M. Balzarotti, G. Cabras, F. Angrilli, A. Fabbri, I. Alvarez, M. Spina
2014 Leukemia & lymphoma Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173patients by the Lymphoma Italian Foundation (FIL). Tucci A1, Martelli M, Rigacci L, Riccomagno P, Cabras MG, Salvi F, Stelitano C, Fabbri A, Storti S, Fogazzi S, Mancuso S, Brugiatelli M, Fama A, Paesano P, Puccini B, Bottelli C, Dalceggio D, Bertagna F, Rossi G, Spina M; Italian Lymphoma Foundation (FIL).
2014 Clinical cancer research Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial. Galimberti S, Luminari S, Ciabatti E, Grassi S, Guerrini F, Dondi A, Marcheselli L, Ladetto M, Piccaluga PP, Gazzola A, Mannu C, Monitillo L, Mantoan B, Del Giudice I, Della Starza I, Cavalli M, Arcaini L, Tucci A, Palumbo GA, Rigacci L, Pulsoni A, Vitolo U, Boccomini C, Vallisa D, Bertoldero G, Gaidano G, Musto P, Petrini M, Federico M.